The past 30 years have seen major advances in the medical care of preterm neonates such that currently more than 95% of the approximately 400 000 preterm infants born each year in the US survive to discharge from the neonatal intensive care unit (NICU). For even the smallest and least mature infants (extremely preterm infants born <28 weeks' gestation), survival is approximately 90%. 1 Given these successes, the focus must now shift from reducing mortality to improving long-term health outcomes in this vulnerable population.Shifting the focus to long-term health requires a clear understanding of the risks that preterm infants face once they leave the NICU. Most pediatricians are aware of the heightened risk of neurodevelopmental impairments, including motor, cognitive, language, and behavioral difficulties. To address these needs, existing infrastructure includes multidisciplinary high-risk infant follow-up clinics and communitybased early-intervention programs, which complement the care provided within the pediatric primary care setting. Typically, high-risk infant follow-up care does not extend beyond childhood.A less well-recognized area of risk for surviving preterm infants is in their cardiometabolic health. Epidemiologic evidence has linked preterm birth with risks of hypertension 2 and type 2 diabetes, 3 with smaller and less mature infants facing the greatest risk of developing these conditions in young adulthood. Some but not all studies have found that preterm birth is also associated with an increased risk of ischemic heart disease in adulthood. 4,5 In contrast with neurodevelopmental concerns, which often lessen in severity over time, particularly when appropriate supports and therapies are in place, cardiometabolic risks may be invisible during early childhood, only to emerge in adolescence, young adulthood, or even middle age.In this issue of JAMA Pediatrics, Crump et al 6 substantially extend our understanding of the cardiometabolic risks faced by infants born preterm by investigating a previously understudied condition, heart failure. In a populationwide study that included more than 4 million participants observed throughout more than 40 years, they found that preterm birth at less than 37 weeks' gestation was associated with a 2.7-fold increased incidence of heart failure compared with full-term (age 39-41 weeks) birth. Stratified analyses revealed several clinically relevant results. First, the risk of heart failure was increased not just for heart failure during infancy (age <1 year, 4.5-fold increased risk) and childhood (age 1-17 years, 3.4fold increased risk), but also for heart failure that presented during adulthood (age 18-43 years, 1.4-fold increased risk).